F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
Sponsor
Technische Universität Dresden (Other)
Overall Status
Terminated
CT.gov ID
NCT00180193
Collaborator
Advanced Biochemical Compounds GmbH (Industry)
40
1
Study Details
Study Description
Brief Summary
The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
Study Start Date
:
Dec 1, 2003
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Brain tumor
-
Radiation therapy indicated
-
Written consent
Exclusion Criteria:
-
Pregnancy
-
Mental impairment
-
Drug/alcohol abuse
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Department of Nuclear Medicine | Dresden | Germany | 01307 |
Sponsors and Collaborators
- Technische Universität Dresden
- Advanced Biochemical Compounds GmbH
Investigators
- Principal Investigator: Joerg Kotzerke, MD, Department of Nuclear Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00180193
Other Study ID Numbers:
- ABX-OMFD-FU
First Posted:
Sep 16, 2005
Last Update Posted:
Aug 26, 2009
Last Verified:
Aug 1, 2009